Background: We recently reported 55% of the patients reversed type 2 diabetes in the continuous care intervention (CCI) while 18% of the patients achieved remission at 2 years. In this post hoc analysis, factors identified in previous studies as predictors of diabetes reversal and remission were examined.
Methods: Baseline factors including diabetes duration, HbA1c, fasting glucose and a composite index (HbA1c, fasting insulin and ALT1) were examined as potential predictors of T2D reversal and remission in the CCI group along with percentage weight loss over the study period. Spearman correlation was used to assess relationships between predictors and 2 years reversal and remission. Factors with significant correlation were analyzed using logistic regression.
Results: Diabetes duration, baseline HbA1c, fasting glucose and the composite index were significantly correlated with diabetes reversal and remission (Table 1). Logistic regression analyses showed that diabetes duration (OR=1.2, p=7.0x10-6) and baseline HbA1c (OR=1.5, p=0.003) were associated with diabetes reversal at 2 years whereas weight loss percentage during the study period was not.
S.J. Athinarayanan: Employee; Self; Virta Health Corp. A. McKenzie: Employee; Self; Virta Health Corp. Stock/Shareholder; Self; Virta Health Corp. R.N. Adams: Employee; Self; Virta Health Corp. S. Hallberg: Advisory Panel; Self; Atkins Nutritionals, Inc. Employee; Self; Virta Health Corp. Stock/Shareholder; Self; Virta Health Corp. J.P. McCarter: Employee; Self; Virta Health Corp. S. Phinney: Advisory Panel; Self; Atkins Nutritionals, Inc. Board Member; Self; Virta Health Corp. Employee; Self; Virta Health Corp. Stock/Shareholder; Self; Virta Health Corp. Other Relationship; Self; Beyond Obesity.
Virta Health Corp
